Save the Date - Friday, March 27!
NEXT NLARx MEETING, MONTPELIER, VERMONT.
Details on agenda and hotel options coming soon. Topics to include: expanding access to affordable prescription drugs through 340B; update on trade issues; the latest action in Congress on reimportation, Medicare PartD, sunshine law and more; gift bans and disclosure legislation in Vermont and other states.
|
NLARx In the News
NLARx Director Sharon Treat Featured in Article on Physican Payments Sunshine Act More
Rep. Cindy Rosenwald Featured in Article on Academic Detailing More
|
In the States
VERMONT: President Pro Tem Shumlin Bill To Report Data on Industry Payments and Ban Gifts More
NLARx Director Treat Testifies in Support of Shumlin Bill More
S. 48 Cost Saving Suggestions Submitted by NLARx to Vermont Senate Finance Committee More
Lawmakers Reject Cut in Pharmacy Program More
NORTH DAKOTA: Big Drugstores Take Aim at Pharmacy Law More
WASHINGTON: Bill to Keep Prescription Data From Drug Firms More
NEW YORK: Consumer Advocates Want Ban On Large Gifts to Doctors More
NEW JERSEY: Committee Advances Bill to Regulate PBM Companies More
MASSACHUSETTS: Attorneys Claim Compliance Woes, Uncertainties Surround New Gift Reporting Law More
WEST VIRGINIA: Project Promotes Generic Drugs More
|
Outrage of the Week
Insurers Overcharged Beneficiaries, Taxpayers by 'Several Billion Dollars' for Medicare Part D More
|
Fraud & Abuse
Insurers Accused of Overcharging Medicare Billions for Drugs More
Bayer to Air 'Corrective' Ads for Contraceptive More
Glaxo's $400 Million Legal Reserve More
|
Prices and Access to Healthcare
Health Insurance and Access to Health Care - The Evidence More
Expanding Medicare Coverage for Off-Label Cancer Drugs Drives Up Cost, NYT Editorial States More
Where $208B in Medication Money Goes More
Study: 36 Million Americans in 2007 Without Prescribed Medications
Because of Cost
More
Analysis of Leading Congressional Health Care Bills, 2007-08: Part I, Insurance Coverage More
Achieving Universal Coverage with Private and Public Group Health Insurance More
Health Care Opinion Leaders' Views on Priorities for the Obama Administration More
Losing Ground: How the Loss of Adequate Health Insurance Is Burdening
Working Families More
|
Advertising and Marketing
Research Tools on State Marketing and Payments Disclosure Laws and Data More
Bitter Pill - The Marketing of Zyprexa More
Allergan Launches First-Ever Consumer Rebate for Botox More
Fibromyalgia Grants Raise Eyebrows More
The Future of Media and Social Marketing More
|
Conflicts of Interest
Harvard Set To Strengthen Conflict-of-Interest Policies at Medical School, Affiliated Hospitals More
Harvard to stiffen rules for staff at med school More
Pfizer to Disclose Payments to Doctors More
Disclosure of Research Payments: One step Forward, Two Steps Back? More
|
Pharma Watch
Drug Makers Fight Stimulus Provision To Fund Research Comparing Medical Treatments More
Roche CEO Pay Rises as Profits Fall More
Roche Talks Up Genentech Deal Again More
AstraZeneca to Shed 15,000 Jobs in 2009 More
Glaxo Prepares to Ax 6,000 More Jobs More
Glaxo Net Falls 7.1%; Job Cuts Planned More
ePharma Summit: Practicing What's Preached! More
Pfizer's PR Chief: "How in the hell do we have such a bad reputation?" More
Disease Charities Invest in Drug Start-Ups More
The Pfizer-Wyeth Deal and the Supreme Court More
P&G Eyes Exit From Prescription Drugs More
J&J's Stoffels Says 'Open Innovation' is the R&D Answer More
|
PBM Watch
A Battle Over Mail-Order Drugs More
PBM Trade Association: It's Time for Comparative Effectiveness More
|
Medicare
Medicare Part D Beneficiaries Cut Back on Prescription Drugs by 14% After Reaching 'Donut Hole' More
Humana's Hit By Rising Drug-Plan Costs - Profit Drops 28% More
Medicare Doctor Data Should Remain Private, Court Says More
Soaring Cancer Drug Costs May Cripple Medicare More
Boston Globe Examines Debate Over Cost Effectiveness of Mail-Order Pharmacies More
Medicare 'Rip-Off' Hits Elderly; Changes Mapped More
|
Medicaid
Rhode Island House Approves Oversight Bill for 'Global Medicaid Waiver' More
States Wrestle Over Medicaid Funds in Stimulus Package More
|
Patents and Generics
Senate Legislation To End Agreements Between Brand-Name, Generic Drug Companies More
FTC Sues Over 'Pay-for-Delay' Generics Deal More
FTC Sues in 'Pay-for-Delay' Pact More
Feds Challenge Deal On Generic Testosterone Gel MoreLA Times Editorial on 'Pay-for-Delay' Schemes More
Brazil Intervenes at WTO General Council on seizure of generic medicines by Dutch customs More
|
Safety and Clinical Trials
Pfizer Faces Celebrex, Trovan Lawsuits More
Generic Toprol XL Scarce, After Problems at Novartis and KV More
FDA and Doctors Look to Cut Abuse of Painkillers More
FDA Panel Gives Prasugrel Thumbs-Up More
Senate Amendment to Stimulus Packages Includes $6.5 Billion for Medical Research at NIH More
PhRMA Statement on Comparative Clinical Effectiveness Research More
Study Claims Decline in Breast Cancer Can Be Credited to a 2002 Aarning Against Overuse of Hormone Drugs More |
Electronic Records
Google To Partner With IBM To Allow Consumers To Add Data to Health Records More
Google Opposes Sale of Personal Medical Info More
Software Allows Some Practices to Quickly Determine a Patient's Share of Healthcare Costs More
Obama Proposes Computerizing Medical Records Within Five Years; Consumers Worried About Privacy More
|
Inside Congress
Senate Passes Stimulus with $19B for Health IT More
Philadelphia Inquirer Examines Sen. Grassley's Efforts To Overhaul Pharmaceutical Industry, FDA More
|
Fellowships
Directory of Health Policy Fellowships More |
